The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database

Introduction: Metaplastic breast cancer (MBC) is a rare and aggressive form of breast cancer. The present study aimed to assess the effect of post-mastectomy radiotherapy (PMRT) in MBC patients with intermediate-risk (T1-2N1M0 and T3N0M0) and high-risk (T1-4N2-3M0 and T4N0-1M0) disease.Methods: The...

Full description

Bibliographic Details
Main Authors: Jun Wang, Wen-Wen Zhang, Chen-Lu Lian, Jia-Yuan Sun, Zhen-Yu He, San-Gang Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00747/full
_version_ 1819178208283590656
author Jun Wang
Wen-Wen Zhang
Chen-Lu Lian
Jia-Yuan Sun
Zhen-Yu He
San-Gang Wu
author_facet Jun Wang
Wen-Wen Zhang
Chen-Lu Lian
Jia-Yuan Sun
Zhen-Yu He
San-Gang Wu
author_sort Jun Wang
collection DOAJ
description Introduction: Metaplastic breast cancer (MBC) is a rare and aggressive form of breast cancer. The present study aimed to assess the effect of post-mastectomy radiotherapy (PMRT) in MBC patients with intermediate-risk (T1-2N1M0 and T3N0M0) and high-risk (T1-4N2-3M0 and T4N0-1M0) disease.Methods: The Surveillance, Epidemiology and End Results database was used to analyze patients with MBC between 2000 and 2014. Kaplan–Meier analysis, log-rank tests, and the multivariate Cox proportional model were used for statistical analysis.Results: We identified 460 patients with a median follow-up time of 31 months (range, 2–178 months). Five-year breast cancer specific survival (BCSS) for all patients was 57.5%. In the entire group, multivariate analysis showed that PMRT was associated with better BCSS (hazard ratio (HR) 0.500, 95% confidence interval (CI) 0.366–0.683, P < 0.001). The 5-year BCSS in PMRT and non-PMRT groups were 62.3 and 50.3%, respectively (P = 0.001). When stratified the patients into intermediate-risk and high-risk groups, PMRT could improve BCSS compared with that in non-PMRT patients in both the intermediate- and high-risk groups. For the intermediate-risk group, the 5-year BCSS was 74.3 and 64.7% in PMRT and non-PMRT groups (P = 0.042), respectively, and was 52.1 and 28.8% in high-risk patients treated with PMRT and non-PMRT, respectively (P < 0.001).Conclusion: PMRT could improve the BCSS of MBC patients with intermediate- and high-risk disease.
first_indexed 2024-12-22T21:38:54Z
format Article
id doaj.art-cb974f66a22749c1ae2c03ab9b9880d8
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-22T21:38:54Z
publishDate 2019-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-cb974f66a22749c1ae2c03ab9b9880d82022-12-21T18:11:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-08-01910.3389/fonc.2019.00747469437The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER DatabaseJun Wang0Wen-Wen Zhang1Chen-Lu Lian2Jia-Yuan Sun3Zhen-Yu He4San-Gang Wu5Department of Radiation Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, ChinaState Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Radiation Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, ChinaState Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaState Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Radiation Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, ChinaIntroduction: Metaplastic breast cancer (MBC) is a rare and aggressive form of breast cancer. The present study aimed to assess the effect of post-mastectomy radiotherapy (PMRT) in MBC patients with intermediate-risk (T1-2N1M0 and T3N0M0) and high-risk (T1-4N2-3M0 and T4N0-1M0) disease.Methods: The Surveillance, Epidemiology and End Results database was used to analyze patients with MBC between 2000 and 2014. Kaplan–Meier analysis, log-rank tests, and the multivariate Cox proportional model were used for statistical analysis.Results: We identified 460 patients with a median follow-up time of 31 months (range, 2–178 months). Five-year breast cancer specific survival (BCSS) for all patients was 57.5%. In the entire group, multivariate analysis showed that PMRT was associated with better BCSS (hazard ratio (HR) 0.500, 95% confidence interval (CI) 0.366–0.683, P < 0.001). The 5-year BCSS in PMRT and non-PMRT groups were 62.3 and 50.3%, respectively (P = 0.001). When stratified the patients into intermediate-risk and high-risk groups, PMRT could improve BCSS compared with that in non-PMRT patients in both the intermediate- and high-risk groups. For the intermediate-risk group, the 5-year BCSS was 74.3 and 64.7% in PMRT and non-PMRT groups (P = 0.042), respectively, and was 52.1 and 28.8% in high-risk patients treated with PMRT and non-PMRT, respectively (P < 0.001).Conclusion: PMRT could improve the BCSS of MBC patients with intermediate- and high-risk disease.https://www.frontiersin.org/article/10.3389/fonc.2019.00747/fullbreast neoplasmsradiotherapymastectomylymph node metastasissurvivalSEER
spellingShingle Jun Wang
Wen-Wen Zhang
Chen-Lu Lian
Jia-Yuan Sun
Zhen-Yu He
San-Gang Wu
The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
Frontiers in Oncology
breast neoplasms
radiotherapy
mastectomy
lymph node metastasis
survival
SEER
title The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
title_full The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
title_fullStr The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
title_full_unstemmed The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
title_short The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
title_sort effect of post mastectomy radiotherapy in patients with metaplastic breast cancer an analysis of seer database
topic breast neoplasms
radiotherapy
mastectomy
lymph node metastasis
survival
SEER
url https://www.frontiersin.org/article/10.3389/fonc.2019.00747/full
work_keys_str_mv AT junwang theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT wenwenzhang theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT chenlulian theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT jiayuansun theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT zhenyuhe theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT sangangwu theeffectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT junwang effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT wenwenzhang effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT chenlulian effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT jiayuansun effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT zhenyuhe effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase
AT sangangwu effectofpostmastectomyradiotherapyinpatientswithmetaplasticbreastcancerananalysisofseerdatabase